Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ph-III Randomized, Multicentric, Controlled , Non-inferiority Trial to Evaluate the Safety and Efficacy of Mupirocin Gel 20 mg/g Versus Mupirocin Ointment 20 mg/g and Placebo in the Treatment of Impetigo in Paediatric Population

NCT04287777 is registered in ClinicalTrials.gov with Reig Jofre Group as lead sponsor.

NCT NCT04287777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04287777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ph-III Randomized, Multicentric, Controlled , Non-inferiority Trial to Evaluate the Safety and Efficacy of Mupirocin Gel 20 mg/g Versus Mupirocin Ointment 20 mg/g and Placebo in the Treatment of Impetigo in Paediatric Population
Lead sponsor
Reig Jofre Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
November 30, 2016
Enrollment
467 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

impetigo